Display options
Share it on

J Hum Reprod Sci. 2017 Jan-Mar;10(1):10-17. doi: 10.4103/0974-1208.204018.

Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome.

Journal of human reproductive sciences

Angela M Alvarez, Stefan Neubeck, Sergio Parra, Udo R Markert, Angela P Cadavid

Affiliations

  1. Reproduction Group, Department of Microbiology and Parasitology, School of Medicine, Universidad de Antioquia, Medellín, Colombia.
  2. Department of Obstetrics, University Hospital Jena, Jena, Germany.
  3. Department of Pharmacology and Toxicology, Universidad de Antioquia, Medellín, Colombia.

PMID: 28479750 PMCID: PMC5405641 DOI: 10.4103/0974-1208.204018

Abstract

CONTEXT: Antiphospholipid antibodies (aPL) are related with a high risk of pregnancy morbidity (PM) and also of vascular thrombosis. On the basis of recent studies, we expect that in women with PM associated with antiphospholipid syndrome (APS), further factors may be deregulated and involved in pathophysiology of the disease. Such factors may have the potential to become novel biomarkers for APS and its stages.

SETTINGS AND DESIGN: Descriptive study from a recurrent pregnancy loss program.

AIMS: To study the protein expression in sera from women with PM with or without aPL.

MATERIALS AND METHODS: Protein profiles were determined by surface enhanced laser desorption and ionization - time of flight mass spectrometry (SELDI-TOF MS) in the serum samples from women with PM, 10 of them with aPL and 12 without aPL. On the basis of the mass-to-charge ratio (

STATISTICAL ANALYSIS USED: To determine the differential expression of each protein, a no paired

RESULTS: SELDI-TOF analysis makes it possible to discriminate between several proteins in women with PM with and without aPL, although it does not allow protein identification. Nine proteins were found in significantly higher levels in aPL-positive women.

CONCLUSION: The results underline that further factors beyond autoantibodies are involved in PM associated with APS and might lead to the development of new biomarkers.

Keywords: Antiphospholipid antibodies; SELDI-TOF MS; pregnancy loss; proteomics

Conflict of interest statement

There are no conflicts of interest.

References

  1. J Hum Reprod Sci. 2014 Jul;7(3):206-11 - PubMed
  2. Biochem Biophys Res Commun. 2001 Jun 8;284(2):289-94 - PubMed
  3. Nat Rev Rheumatol. 2011 Jun;7(6):330-9 - PubMed
  4. J Proteome Res. 2005 Mar-Apr;4(2):613-9 - PubMed
  5. Blood. 2014 Dec 11;124(25):3808-16 - PubMed
  6. Molecules. 2009 Nov 30;14(12):4892-914 - PubMed
  7. J Reprod Immunol. 1992 Jun;22(1):15-31 - PubMed
  8. J Am Soc Mass Spectrom. 2007 Jul;18(7):1249-64 - PubMed
  9. Am J Reprod Immunol. 1998 Feb;39(2):120-4 - PubMed
  10. Thromb Res. 2009 Nov;124(5):521-5 - PubMed
  11. Proteomics. 2010 Mar;10(6):1250-5 - PubMed
  12. J Proteome Res. 2011 Mar 4;10(3):1151-9 - PubMed
  13. Lupus. 2003;12(7):535-8 - PubMed
  14. Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii46-50 - PubMed
  15. Scand J Immunol. 2010 May;71(5):317-28 - PubMed
  16. Methods. 2012 Feb;56(2):284-92 - PubMed
  17. Blood. 2009 Mar 26;113(13):3027-30 - PubMed
  18. Arthritis Rheum. 2008 Sep;58(9):2835-44 - PubMed
  19. J Environ Pathol Toxicol Oncol. 2004;23(1):1-11 - PubMed
  20. Methods. 2011 Aug;54(4):361-9 - PubMed
  21. Am J Pathol. 2013 Nov;183(5):1425-36 - PubMed
  22. Behring Inst Mitt. 1995 Jun;(96):58-77 - PubMed
  23. Med Hypotheses. 2011 Jan;76(1):8-10 - PubMed
  24. Proteomics. 2005 Aug;5(13):3343-52 - PubMed
  25. J Proteome Res. 2010 Oct 1;9(10):5164-70 - PubMed
  26. Nat Med. 2004 Nov;10(11):1222-6 - PubMed
  27. Lupus. 2011 Feb;20(2):191-205 - PubMed
  28. Clin Rev Allergy Immunol. 2010 Apr;38(2-3):141-7 - PubMed
  29. J Proteome Res. 2005 Jul-Aug;4(4):1265-73 - PubMed
  30. Arthritis Rheumatol. 2015 Feb;67(2):488-97 - PubMed
  31. Lancet. 2010 Mar 6;375(9717):778 - PubMed
  32. PLoS One. 2011 Feb 18;6(2):e17213 - PubMed
  33. Proteomics Clin Appl. 2009 Feb;3(2):213-25 - PubMed
  34. Electrophoresis. 2011 Aug;32(15):1970-5 - PubMed
  35. J Cell Physiol. 2012 Mar;227(3):1034-41 - PubMed
  36. J Reprod Immunol. 2008 Jan;77(1):51-6 - PubMed
  37. Acta Med Port. 2011 Sep-Oct;24(5):833-6 - PubMed
  38. Curr Opin Immunol. 2012 Dec;24(6):658-64 - PubMed
  39. J Rheumatol. 1994 Sep;21(9):1684-93 - PubMed
  40. Lupus. 2010 Apr;19(4):385-8 - PubMed
  41. J Exp Med. 2002 Jan 21;195(2):211-20 - PubMed
  42. BMC Cancer. 2013 Feb 26;13:91 - PubMed
  43. J Clin Endocrinol Metab. 2010 Aug;95(8):3863-70 - PubMed
  44. J Immunol. 2010 Jun 15;184(12):6622-8 - PubMed
  45. J Thromb Haemost. 2006 Feb;4(2):295-306 - PubMed
  46. Curr Opin Hematol. 2006 Sep;13(5):366-75 - PubMed
  47. Nat Clin Pract Rheumatol. 2007 Mar;3(3):140-7; quiz 1 p following 187 - PubMed
  48. J Clin Invest. 2003 Dec;112(11):1644-54 - PubMed
  49. Proteomics Clin Appl. 2015 Feb;9(1-2):48-57 - PubMed
  50. Ann N Y Acad Sci. 2007 Jun;1108:505-14 - PubMed
  51. Autoimmunity. 2003 Feb;36(1):19-26 - PubMed
  52. Nucleic Acids Res. 2012 Jan;40(Database issue):D261-70 - PubMed
  53. Proteomics. 2005 Feb;5(2):572-84 - PubMed
  54. BMC Med Genomics. 2011 Mar 25;4:24 - PubMed
  55. Semin Arthritis Rheum. 2012 Apr;41(5):720-36 - PubMed

Publication Types